Pakistan is one of the first three countries who will manufacture and export the medicine.

Has Pakistan got the right to manufacture remdesivir? The claim comes from Pakistan’s Advisor to Prime Minister on Health Dr. Zafar Mirza

Has Pakistan got the right to manufacture remdesivir? The claim is true as one of the famous pharmaceutical brands speaks out on it. Pakistani company Ferozsons Laboratories Limited have got the license for it. The CEO of Ferozsons Laboratories Osman Khalid Waheed claims that the production will start within weeks.

Remdesivir is a broad-spectrum antiviral medication by the bio-pharmaceutical company Gilead Sciences. As of 2020, remdesivir is in testing phase as a specific treatment for COVID-19, and has been authorized for emergency use in the U.S. and approved for use in Japan for people with severe symptoms. In fact, Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19.

Thus, Pakistan is one of the first three countries around the world which has got the right to produce and export the medicine. It also gives an immense boost to the country’s economy. Pakistan’s economy is facing harsh outcome after closure of business and semi lock-down in the country.

The latest reports also claim that the remittance is also decreasing in the country. Thus, it required a strong support to its economy to deal with its high debts, declining employment rates and increasing poverty. This may serve as a strong breather.

Pakistan expects to export the medicine to 127 countries across the world. This may result in a huge inflow of foreign exchange in the country. The decision to produce the medicine was announced in a press conference. The Advisor to Prime Minister on Health, Dr. Zafar Mirza was also in attendance.

So, Yes, Pakistan has got the right to manufacture remdesivir.